{"DataElement":{"publicId":"2960122","version":"1","preferredName":"Intervention Trial Study Protocol Document Trial Phase Code PhaseCode","preferredDefinition":"A pre-clinical or clinical study in human beings in which individuals are assigned by an investigator based on a protocol to receive specific interventions. The individuals are then followed and biomedical and/or health outcomes are assessed.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data._Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed.:A system, often of numbered categories, for representation of data._The code that describes the designation of the approval phase for a study protocol.","longName":"2868798v1.0:2959653v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2868798","version":"1","preferredName":"Intervention Trial Study Protocol Document Trial Phase Code","preferredDefinition":"A pre-clinical or clinical study in human beings in which individuals are assigned by an investigator based on a protocol to receive specific interventions. The individuals are then followed and biomedical and/or health outcomes are assessed.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data._Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed.:A system, often of numbered categories, for representation of data.","longName":"2867669v1.0:2607562v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2867669","version":"1","preferredName":"Intervention Trial Study Protocol Document","preferredDefinition":"A pre-clinical or clinical study in human beings in which individuals are assigned by an investigator based on a protocol to receive specific interventions. The individuals are then followed and biomedical and/or health outcomes are assessed.:A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.:A rule which guides how an activity should be performed.:An organized collection of records that describe a particular body of data.","longName":"C16140:C63536:C42651:C19498","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intervention Trial","conceptCode":"C16140","definition":"A pre-clinical or clinical study in human beings in which individuals are assigned by an investigator based on a protocol to receive specific interventions. The individuals are then followed and biomedical and/or health outcomes are assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Study","conceptCode":"C63536","definition":"A detailed examination, analysis, or critical inspection of a subject designed to discover facts about it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Protocol","conceptCode":"C42651","definition":"A rule which guides how an activity should be performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Document","conceptCode":"C19498","definition":"A physical object, or electronic counterpart, that is characterized by containing writing which is meant to be human-readable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"694174B2-D8AB-D6FE-E040-BB89AD4374D5","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2009-05-06","modifiedBy":"ONEDATA","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2607562","version":"1","preferredName":"Trial Phase Code","preferredDefinition":"Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed.:A system, often of numbered categories, for representation of data.","longName":"C48281:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trial Phase","conceptCode":"C48281","definition":"Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AF30087-8453-6F3F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-05","endDate":null,"createdBy":"UMLLOADER_CTOM","dateCreated":"2007-03-05","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6941BDC2-1462-CF16-E040-BB89AD436906","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"UMLLOADER_BRIDGPRD","dateCreated":"2009-05-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"4/7/11 - no longer used by BRIDG; released for reuse by COPPA","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2959653","version":"1","preferredName":"PhaseCode","preferredDefinition":"The code that describes the designation of the approval phase for a study protocol.","longName":"2959653v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"ISO21090CDv1.0","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"Phase 0 Trial","ValueMeaning":{"publicId":"2698170","version":"1","preferredName":"Phase 0 Trial","longName":"2698170","preferredDefinition":"A clinical trial that uses an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited.  ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase 0 Trial","conceptCode":"C54721","definition":"A clinical trial that uses an investigational agent that is available only in very limited quantities and which has never previously given to humans or for which there is extremely limited human experience. Phase 0 clinical trials are intended to enable researchers to understand the path of the drug in the body and its efficacy. Adverse event reporting in Phase 0 trials is expedited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3FEC515A-6612-1907-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2007-11-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77FB5771-AEEF-2FA1-E040-BB89AD4307F2","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ONEDATA","dateModified":"2009-11-09","deletedIndicator":"No"},{"value":"I","valueDescription":"Phase I Trial","ValueMeaning":{"publicId":"2578679","version":"1","preferredName":"Phase I Trial","longName":"2578679","preferredDefinition":"A clinical research protocol designed to test a new biomedical intervention in a small group of people for the first time. A Phase I trial can be to establish the toxicity of a new treatment with escalating intensity of the treatment administered and/or to determine the side effects of a new treatment for a particular indication in subjects. \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase I Trial","conceptCode":"C15600","definition":"A clinical research protocol designed to test a new biomedical intervention in a small group of people for the first time. A Phase I trial can be to establish the toxicity of a new treatment with escalating intensity of the treatment administered and/or to determine the side effects of a new treatment for a particular indication in subjects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0064-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"TAYLORT","dateModified":"2020-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77FB5771-AEF8-2FA1-E040-BB89AD4307F2","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ONEDATA","dateModified":"2009-11-09","deletedIndicator":"No"},{"value":"I/II","valueDescription":"Phase I/II Trial","ValueMeaning":{"publicId":"2578680","version":"1","preferredName":"Phase I/II Trial","longName":"2578680","preferredDefinition":"A clinical research protocol designed to study the safety, dosage levels and response to new treatment. Phase I/II trials combine a Phase I and a Phase II trial of the same treatment into a single protocol.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase I/II Trial","conceptCode":"C15693","definition":"A clinical research protocol designed to study the safety, dosage levels and response to new treatment. Phase I/II trials combine a Phase I and a Phase II trial of the same treatment into a single protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0065-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"SBREXT","dateModified":"2007-06-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77FB5771-AF01-2FA1-E040-BB89AD4307F2","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ONEDATA","dateModified":"2009-11-09","deletedIndicator":"No"},{"value":"II","valueDescription":"Phase II Trial","ValueMeaning":{"publicId":"2578681","version":"1","preferredName":"Phase II Trial","longName":"2578681","preferredDefinition":"A clinical research protocol designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention. \r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase II Trial","conceptCode":"C15601","definition":"A clinical research protocol designed to study a biomedical or behavioral intervention in a larger group of people (several hundred), to evaluate the drug's effectiveness for a particular indication in patients with the disease or condition under study, and to determine the common short-term side effects and risks associated with the intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0066-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"TAYLORT","dateModified":"2020-08-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77FB5771-AF0A-2FA1-E040-BB89AD4307F2","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ONEDATA","dateModified":"2009-11-09","deletedIndicator":"No"},{"value":"II/III","valueDescription":"Phase II/III Trial","ValueMeaning":{"publicId":"2579213","version":"1","preferredName":"Phase II/III Trial","longName":"2579213","preferredDefinition":"A trial to study response to a new treatment and the effectiveness of the treatment compared with the standard treatment regimen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase II/III Trial","conceptCode":"C15694","definition":"A type of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-027A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-07","modifiedBy":"ONEDATA","dateModified":"2006-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77FB5771-AF13-2FA1-E040-BB89AD4307F2","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ONEDATA","dateModified":"2009-11-09","deletedIndicator":"No"},{"value":"III","valueDescription":"Phase III Trial","ValueMeaning":{"publicId":"2578682","version":"1","preferredName":"Phase III Trial","longName":"2578682","preferredDefinition":"A study to compare the results of people taking a new treatment with the results of people taking the standard treatment (for example, which group has better survival rates or fewer side effects). In most cases, studies move into phase III only after a treatment seems to work in phases I and II. Phase III trials may include hundreds of people.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase III Trial","conceptCode":"C15602","definition":"A clinical research protocol designed to investigate the efficacy of the biomedical or behavioral intervention in large groups of human subjects (from several hundred to several thousand), to confirm efficacy, to monitor adverse reactions to the new medication or treatment regimen with respect to long-term use and by comparing the intervention to other standard or experimental interventions as well as to a placebo.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0067-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77FB5771-AF1C-2FA1-E040-BB89AD4307F2","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ONEDATA","dateModified":"2009-11-09","deletedIndicator":"No"},{"value":"IV","valueDescription":"Phase IV Trial","ValueMeaning":{"publicId":"2578683","version":"1","preferredName":"Phase IV Trial","longName":"2578683","preferredDefinition":"Generally, a Phase IV trial is a randomized, controlled trial that is designed to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase IV Trial","conceptCode":"C15603","definition":"A randomized, controlled trial that is designed to evaluate the long-term safety and efficacy of a drug for a given indication. Often they are designed to study side effects that may have become apparent after the phase III study was completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0068-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77FB5771-AF25-2FA1-E040-BB89AD4307F2","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ONEDATA","dateModified":"2009-11-09","deletedIndicator":"No"},{"value":"Pilot","valueDescription":"Pilot Study","ValueMeaning":{"publicId":"2959654","version":"1","preferredName":"Pilot Study","longName":"2959654","preferredDefinition":"The initial study examining a new method or treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pilot Study","conceptCode":"C15303","definition":"The initial study examining a new method or treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77FB5771-AF30-2FA1-E040-BB89AD4307F2","latestVersionIndicator":"Yes","beginDate":"2009-11-09","endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77FB5771-AF46-2FA1-E040-BB89AD4307F2","beginDate":null,"endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ONEDATA","dateModified":"2009-11-09","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A391AEC-03E3-397F-E040-BB89AD430848","beginDate":"2009-12-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-08","modifiedBy":"ONEDATA","dateModified":"2009-12-08","deletedIndicator":"No"},{"value":"N/A","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"2838911","version":"1","preferredName":"Not Applicable","longName":"2838911","preferredDefinition":"Determination that a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62AB59ED-A641-4EBE-E040-BB89AD4348C8","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"CLOHNES","dateModified":"2022-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7A391AEC-03ED-397F-E040-BB89AD430848","beginDate":"2009-12-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-12-08","modifiedBy":"ONEDATA","dateModified":"2009-12-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261841","version":"1","preferredName":"Code","preferredDefinition":"A system of numbered categories for representation of data.","longName":"C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FBB87F7A-6427-1AFC-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-07-13","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77FB5771-AED5-2FA1-E040-BB89AD4307F2","latestVersionIndicator":"Yes","beginDate":"2009-11-09","endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"CHILLIJ","dateModified":"2012-07-29","changeDescription":"7/29/12 - Released as part of C3PR v2.8 model cleanup.  Associated VD with C3PR CS/CSI. jc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2958963","version":"1","longName":"COPPA","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2958964","version":"1","longName":"gov.nih.nci.COPPA.InformationModel","context":"NCIP"}]}],"AlternateNames":[{"name":"InterventionalStudyProtocol:phaseCode","type":"UML Class:UML Attr","context":"NCIP"},{"name":"gov.nih.nci.COPPA.InformationModel.InterventionalStudyProtocol.phaseCode","type":"UML Qualified Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Data Element Intervention Trial Study Protocol Document Trial Phase Code PhaseCode does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Intervention Trial Study Protocol Document Trial Phase Code PhaseCode does not have Preferred Question Text","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"77FB9CF7-4F0F-3540-E040-BB89AD433935","latestVersionIndicator":"Yes","beginDate":"2009-11-09","endDate":null,"createdBy":"UMLLOADER_COPPAPRD","dateCreated":"2009-11-09","modifiedBy":"ZHANGW","dateModified":"2021-08-18","changeDescription":"8/18/2021wz: released for UML model cleanup project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}